DE69322007D1 - Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika - Google Patents

Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika

Info

Publication number
DE69322007D1
DE69322007D1 DE69322007T DE69322007T DE69322007D1 DE 69322007 D1 DE69322007 D1 DE 69322007D1 DE 69322007 T DE69322007 T DE 69322007T DE 69322007 T DE69322007 T DE 69322007T DE 69322007 D1 DE69322007 D1 DE 69322007D1
Authority
DE
Germany
Prior art keywords
carbapeneme
antibiotics
production
phenyl group
group containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69322007T
Other languages
English (en)
Other versions
DE69322007T2 (de
Inventor
Michael John Betts
Gareth Morse Davies
Michael Lingard Swain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Syngenta Ltd
Original Assignee
Zeneca Pharma SA
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA, Zeneca Ltd filed Critical Zeneca Pharma SA
Publication of DE69322007D1 publication Critical patent/DE69322007D1/de
Application granted granted Critical
Publication of DE69322007T2 publication Critical patent/DE69322007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69322007T 1992-02-04 1993-02-02 Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika Expired - Lifetime DE69322007T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (2)

Publication Number Publication Date
DE69322007D1 true DE69322007D1 (de) 1998-12-17
DE69322007T2 DE69322007T2 (de) 1999-04-01

Family

ID=10709764

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69322007T Expired - Lifetime DE69322007T2 (de) 1992-02-04 1993-02-02 Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika
DE2002199041 Active DE10299041I2 (de) 1992-02-04 1993-02-02 Carboxy substituierte Phenylgruppe enthaltende Carbapeneme; Verfahren zu deren Herstellung, Zwischenprodukte und Verwendung als Antibiotika.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2002199041 Active DE10299041I2 (de) 1992-02-04 1993-02-02 Carboxy substituierte Phenylgruppe enthaltende Carbapeneme; Verfahren zu deren Herstellung, Zwischenprodukte und Verwendung als Antibiotika.

Country Status (35)

Country Link
US (7) US5478820A (de)
EP (1) EP0579826B1 (de)
JP (1) JP2730600B2 (de)
KR (1) KR100200986B1 (de)
CN (1) CN1036006C (de)
AP (1) AP398A (de)
AT (1) ATE173262T1 (de)
AU (1) AU668133B2 (de)
CA (1) CA2106370C (de)
CZ (1) CZ286878B6 (de)
DE (2) DE69322007T2 (de)
DK (1) DK0579826T3 (de)
ES (1) ES2123654T3 (de)
FI (1) FI104074B1 (de)
GB (2) GB9202298D0 (de)
GE (1) GEP20022694B (de)
HK (1) HK1013998A1 (de)
HR (1) HRP930103B1 (de)
HU (3) HUT66514A (de)
IL (1) IL104588A (de)
LU (1) LU90970I2 (de)
MY (1) MY111685A (de)
NL (1) NL300104I2 (de)
NO (2) NO304315B1 (de)
NZ (2) NZ272038A (de)
PL (3) PL174601B1 (de)
RU (1) RU2117659C1 (de)
SG (1) SG48817A1 (de)
SI (1) SI9300056B (de)
SK (1) SK280890B6 (de)
TW (1) TW408124B (de)
UA (1) UA44885C2 (de)
WO (1) WO1993015078A1 (de)
YU (1) YU48998B (de)
ZA (1) ZA93453B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
US6946468B1 (en) 1996-08-17 2005-09-20 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
ATE229962T1 (de) * 1996-10-10 2003-01-15 Merck & Co Inc Verfahren zur herstellung von zwischenprodukten in herstellung von carbapenem-seitenketten
AU725298B2 (en) * 1996-10-28 2000-10-12 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
DE69819727T2 (de) * 1997-06-16 2004-09-23 Merck & Co., Inc. Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
WO1999002492A1 (en) * 1997-07-10 1999-01-21 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
ATE321762T1 (de) * 1998-03-02 2006-04-15 Merck & Co Inc Verfahren zur synthese von carbapenem-antibiotika
US6489471B1 (en) 1998-06-17 2002-12-03 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
USRE40794E1 (en) 2001-09-26 2009-06-23 Merck & Co., Inc. Crystalline forms of carbapenem antibiotics and methods of preparation
UA78524C2 (en) 2001-09-26 2007-04-10 Merck & Co Inc A process for preparation of carbapenem compounds
US20040186089A1 (en) * 2001-11-08 2004-09-23 Scolnick Edward M. Compounds useful in the treatment of anthrax
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
KR100701811B1 (ko) * 2002-05-29 2007-04-02 머크 앤드 캄파니 인코포레이티드 탄저병의 치료 및 치사 인자의 억제에 유용한 화합물
WO2005111986A2 (en) * 2004-05-07 2005-11-24 Infinium Labs, Inc. Multi-position multi-level user interface system
CA2566191A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
CA2629570C (en) 2005-12-07 2012-11-27 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2008062279A2 (en) * 2006-11-20 2008-05-29 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505190A1 (de) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphe Form eines Ertapenem-Mononatriums und dessen Herstellungsprozess
PT2326648E (pt) * 2008-07-30 2012-10-31 Ranbaxy Lab Ltd Processo de preparação de compostos de carbapenem
RU2521391C2 (ru) * 2008-09-18 2014-06-27 Ману ЧАУДХАРИ Новые однократные единичные составы карбапенема и аминогликозида
RU2575979C2 (ru) 2009-04-30 2016-02-27 СиЭсПиСи ЧЖУНЦИ ФАРМАСЬЮТИКАЛ ТЕКНОЛОДЖИ (ШИЦЗЯЧЖУАН)КО., ЛТД. Способ получения промежуточного соединения эртапенема
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
JP2015533142A (ja) * 2012-10-12 2015-11-19 サンド・アクチエンゲゼルシヤフト エルタペネム中間体の製造
AU2014227737B2 (en) * 2013-03-15 2018-05-17 KALA BIO, Inc. Meropenem derivatives and uses thereof
IN2013MU03862A (de) 2013-12-11 2015-07-31 Unimark Remedies Ltd
CA3015309C (en) 2016-03-16 2024-02-13 Orchid Pharma Ltd. Carbapenem compounds
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
SG11202107678UA (en) * 2019-01-23 2021-08-30 Glycolysis Biomed Co Ltd Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
JPS61275279A (ja) * 1984-12-25 1986-12-05 Sankyo Co Ltd カルバペネム化合物
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
FI96863C (fi) * 1990-02-23 1996-09-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
CZ167792A3 (en) * 1991-06-04 1995-12-13 Sankyo Co 1-methylcarbapenem derivatives process of their preparation and use
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
ES2123654T3 (es) 1999-01-16
US20050209212A1 (en) 2005-09-22
FI104074B (fi) 1999-11-15
DE10299041I1 (de) 2003-02-20
US20020042408A1 (en) 2002-04-11
AU3457493A (en) 1993-09-01
CA2106370C (en) 2003-11-25
HUT66514A (en) 1994-12-28
WO1993015078A1 (en) 1993-08-05
NO933530D0 (no) 1993-10-01
SK106393A3 (en) 1994-04-06
SI9300056B (sl) 2000-02-29
HUT64764A (en) 1994-02-28
US5652233A (en) 1997-07-29
NO304315B1 (no) 1998-11-30
JP2730600B2 (ja) 1998-03-25
SK280890B6 (sk) 2000-09-12
DK0579826T3 (da) 1999-07-26
NZ272038A (en) 1997-07-27
GB9300456D0 (en) 1993-03-03
HU211840A9 (en) 1995-12-28
UA44885C2 (uk) 2002-03-15
YU48998B (sh) 2003-04-30
LU90970I2 (fr) 2002-12-09
US5856321A (en) 1999-01-05
CN1036006C (zh) 1997-10-01
KR100200986B1 (ko) 1999-06-15
JPH06506704A (ja) 1994-07-28
NO933530L (no) 1993-10-04
RU2117659C1 (ru) 1998-08-20
CZ286878B6 (en) 2000-07-12
US6187804B1 (en) 2001-02-13
US7041836B2 (en) 2006-05-09
IL104588A0 (en) 1993-06-10
IL104588A (en) 1999-03-12
PL174601B1 (pl) 1998-08-31
CA2106370A1 (en) 1993-08-05
US5478820A (en) 1995-12-26
SI9300056A (en) 1993-09-30
ZA93453B (en) 1993-08-05
MY111685A (en) 2000-11-30
NO2002010I1 (no) 2002-10-09
ATE173262T1 (de) 1998-11-15
US20030144264A1 (en) 2003-07-31
HU9302777D0 (en) 1993-12-28
HK1013998A1 (en) 1999-09-17
FI104074B1 (fi) 1999-11-15
PL174649B1 (pl) 1998-08-31
AU668133B2 (en) 1996-04-26
NO2002010I2 (no) 2005-03-11
US6521612B2 (en) 2003-02-18
NL300104I1 (nl) 2002-12-02
HU213675B (en) 1997-09-29
US7342005B2 (en) 2008-03-11
PL174936B1 (pl) 1998-10-30
YU5493A (sh) 1996-05-20
GB9202298D0 (en) 1992-03-18
CZ206793A3 (en) 1994-04-13
SG48817A1 (en) 1998-05-18
GEP20022694B (en) 2002-05-10
FI930474A0 (fi) 1993-02-03
NL300104I2 (nl) 2003-02-03
EP0579826B1 (de) 1998-11-11
AP398A (en) 1995-08-29
NZ246917A (en) 1995-09-26
HRP930103A2 (en) 1994-12-31
AP9300480A0 (en) 1993-01-31
DE10299041I2 (de) 2003-06-12
TW408124B (en) 2000-10-11
DE69322007T2 (de) 1999-04-01
CN1079224A (zh) 1993-12-08
EP0579826A1 (de) 1994-01-26
HRP930103B1 (en) 1999-12-31
FI930474A (fi) 1993-08-05

Similar Documents

Publication Publication Date Title
DE69322007T2 (de) Carboxy substituierte phenylgruppe enthaltende carbapeneme; verfahren zu deren herstellung, zwischenprodukte und verwendung als antibiotika
ATE228499T1 (de) Benzamidoxim-derivate, zwischenprodukte und verfahren zu deren herstellung und deren verwendung als fungizide
DE69410894D1 (de) 2-Aminothiazolcarboxamid Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Bekämpfung von phytopathogenen Organismen
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
DE59307218D1 (de) Modifizierte polyasparaginsäuren, verfahren zu ihrer herstellung und ihre verwendung
ATE202553T1 (de) Phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende mittel
DE69211076T3 (de) Polyasparaginsäure-zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
DE69632324D1 (de) Pna-dna-chimäre und pna-synthone zu deren herstellung
ATE234291T1 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
DE59307910D1 (de) Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
DE68907057D1 (de) Naehrstoffzusammensetzung und verfahren zu deren herstellung.
DE69433032D1 (de) VERFLÜSSIGENDE -[alpha]-AMYLASE, VERFAHREN ZU IHRER HERSTELLUNG, UND SIE ENTHALTENDE WASCHMITTELZUSAMMENSETZUNG
DE69306615D1 (de) Verbundwalze und Verfahren zu ihrer Herstellung
DE69533160D1 (de) Waschmittelbuilder, verfahren zu seiner herstellung und diesen enthaltende waschmittelzusammensetzung
DE69332117T2 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE58901691D1 (de) Amorphes aluminiumoxid, verfahren zu seiner herstellung und verwendung.
DE69203838D1 (de) Sauerstoff-Absorber und Verfahren zu dessen Herstellung.
DE59805127D1 (de) Pulverlack-zusammensetzung, verfahren zu deren herstellung und deren verwendung
DE69318181T2 (de) Papierblock, streifen und verfahren zu deren herstellung
DE69432756D1 (de) 1,3-oxazin-4-on-derivate, verfahren und zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
AT399880B (de) Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE69630873D1 (de) Propylen-1-penten copolymerisate, verfahren zu deren herstellung und zusammensetzungen diese enthaltend
DE69331047D1 (de) 2-isocephem und -oxacephemderivate,verfahren zu deren herstellung, deren zwischenprodukte und verwendung als antibakterielle mittel
DE59208696D1 (de) Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung